Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program. [electronic resource]
Producer: 20200723Description: 585 p. digitalISSN:- 2045-2322
- Adult
- Aged
- Antiviral Agents -- adverse effects
- Carbamates
- Drug Therapy, Combination -- methods
- Drug-Related Side Effects and Adverse Reactions
- Female
- Hepatitis C, Chronic -- complications
- Humans
- Imidazoles -- adverse effects
- Isoquinolines -- therapeutic use
- Italy
- Liver Cirrhosis -- drug therapy
- Liver Function Tests
- Male
- Middle Aged
- Pyrrolidines
- Ribavirin -- therapeutic use
- Sofosbuvir -- therapeutic use
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.